Health Insurance Innovations, Inc. (NASDAQ:HIIQ) was upgraded by stock analysts at ValuEngine from a “buy” rating to a “strong-buy” rating in a report released on Monday.

A number of other equities analysts also recently issued reports on the company. Canaccord Genuity restated a “buy” rating and issued a $39.00 price target on shares of Health Insurance Innovations in a research note on Wednesday, September 13th. Cantor Fitzgerald reiterated a “buy” rating and set a $38.00 price objective on shares of Health Insurance Innovations in a research report on Monday, September 25th. TheStreet cut Health Insurance Innovations from a “b-” rating to a “c” rating in a research report on Thursday, September 28th. Raymond James Financial, Inc. reissued a “market perform” rating on shares of Health Insurance Innovations in a report on Monday, June 26th. Finally, Zacks Investment Research raised Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $33.00 target price on the stock in a report on Friday, August 4th. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $31.33.

Shares of Health Insurance Innovations (HIIQ) opened at 16.30 on Monday. The firm’s 50-day moving average is $26.86 and its 200 day moving average is $23.07. The stock has a market capitalization of $203.24 million, a P/E ratio of 13.19 and a beta of 0.51. Health Insurance Innovations has a 12-month low of $4.00 and a 12-month high of $37.38.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.13. The business had revenue of $61.80 million during the quarter, compared to the consensus estimate of $53.69 million. Health Insurance Innovations had a net margin of 5.56% and a return on equity of 22.89%. The company’s revenue for the quarter was up 38.9% on a year-over-year basis. On average, equities research analysts forecast that Health Insurance Innovations will post $1.53 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Health Insurance Innovations, Inc. (HIIQ) Stock Rating Upgraded by ValuEngine” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/health-insurance-innovations-inc-hiiq-stock-rating-upgraded-by-valuengine/1607066.html.

In related news, Director Robert S. Murley bought 3,000 shares of the firm’s stock in a transaction that occurred on Friday, September 1st. The shares were bought at an average cost of $30.21 per share, with a total value of $90,630.00. Following the acquisition, the director now owns 34,734 shares in the company, valued at $1,049,314.14. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sheldon Wang sold 4,750 shares of the firm’s stock in a transaction on Thursday, July 13th. The stock was sold at an average price of $25.80, for a total value of $122,550.00. Following the completion of the transaction, the insider now directly owns 224,001 shares in the company, valued at $5,779,225.80. The disclosure for this sale can be found here. In the last three months, insiders have sold 189,827 shares of company stock valued at $5,479,608. Insiders own 30.00% of the company’s stock.

Large investors have recently added to or reduced their stakes in the business. Morgan Stanley increased its position in Health Insurance Innovations by 240.2% in the first quarter. Morgan Stanley now owns 70,397 shares of the financial services provider’s stock worth $1,127,000 after buying an additional 49,703 shares in the last quarter. Tudor Investment Corp ET AL bought a new position in shares of Health Insurance Innovations during the 1st quarter valued at approximately $648,000. Granite Point Capital Management L.P. grew its stake in shares of Health Insurance Innovations by 8.8% during the 2nd quarter. Granite Point Capital Management L.P. now owns 87,900 shares of the financial services provider’s stock valued at $2,066,000 after acquiring an additional 7,100 shares during the period. Timpani Capital Management LLC bought a new position in shares of Health Insurance Innovations during the 2nd quarter valued at approximately $3,674,000. Finally, Vanguard Group Inc. grew its stake in shares of Health Insurance Innovations by 92.2% during the 1st quarter. Vanguard Group Inc. now owns 406,293 shares of the financial services provider’s stock valued at $6,500,000 after acquiring an additional 194,907 shares during the period. 66.21% of the stock is owned by institutional investors and hedge funds.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.